glp-1 protein intake medications may reduce your appetite, but your needs stay the same 💪🍒 Keep your protein on track with Proteinex Core Cherry — a simple and delicious way to support Protein Intake on GLP-1 Medications:

The gut-brain axis: challenging the old GLP-1 model The original theory was simple: food enters the gut the gut releases GLP-1 GLP-1 travels via the bloodstream into the brain GLP-1 induces more GLP-1 release within the brain appetite is suppressed

The pairings that hold up best involve peptides with different mechanisms

3 Nutrient deficiencies are a higher risk for those taking GLP-1 agonists because of decreased appetite and reduced food intake

Kim K-B, Nam YA, Kim HS, Hayes AW, Lee B-M (2014) -Linolenic acid: nutraceutical, pharmacological and toxicological evaluation

STACK Healing Power Trio BPC-157 + TB-500 + MOTS-c as a regeneration-plus-bioenergetics research panel

Semaglutide, better known by brand names such as Wegovy, is a glucagon-like peptide-1 (GLP-1) receptor agonist drug that has been approved by the U.S